l Tuesday, May 7, 1996 Podium Session 26 1:00 pm to 3:00 pm ]

RENAL TRANSPLANTATION AND VASCULAR SURGERY CLINICAL A N D RESEARCH Room 224 A-D, Orange County Convention Center

Moderators: David A. Hatch, Maywood, IL J. Thomas Rosenthal, Los Angeles, CA

(Note: all presentations are 7 minutes in length.)

[:00

I:10

[:20

:30

:40

[:50

#877

#878

#879

#880

#881

#882

Cadaveric renal transplantation using donors over 60 years old-5 year followup.

Carlos A. Vivas, Albin Gritsch, Ron Shapiro, Velma P. Scantlebury, David Hickey, Thomas R. Hakala and Mark L. Jordan, Pittsburgh, PA (Presented by Dr. Vivas).

Beneficial renal hemodynamic effects of Iovas- tatin.

Abraham A. Glazer, Nicholas T. Stowe, Sharon R. Inman and Andrew C. Novick, Cleveland, OH (Presented by Dr. Glazer).

Comparison between laparoscopic versus open llve-donor nephrectomy.

Peter G. Schulam, Robert G. Moore, Robert Montgomery, Timothy D. Averch, Lloyd E. Ratner and Louis R. Kavoussi, Baltimore, MD (Presented by Dr. Schulam).

The current level of involvement of urologic trainees and faculty in clinical kidney transplan- tation.

Stuart M. Flechner and Andrew C. Nov/ok, Cleveland, OH (Presented by Dr. Flechner).

USTVS RESIDENT AWARD - CLINICAL (INTRODUCTION BY DAVID A. HATCH, PRESIDENT, USTVS) Use of cyclosporine pharmacokinetic profiles in an antibody induction protocol reduces early acute rejection rates in recipients of primary cadaveric renal allografts.

Sean Man/on, Janet Coutee, Billie Kostro, Denise Calvert, David Hatch, Rekha Agrawal, Donald Moel, Robert Flanigan and Richard Lewis, Chicago, IL (Presented by Dr. Man/on).

Post-transplant renal artery stenosis: impact of therapy on long-term kidney function and blood pressure control.

Bashir R. Sankari, Michael Geisinger, Margaret Zelch, Ben Brouhard, Robert Cunningham and Andrew C. Novick, Cleveland, OH (Presented by Dr. Sankari).

2:00 #883

2:10

2:20

2:30

2:40

2:50

#884

#885

#886

#887

#888

New onset diabetes mellitus after renal trans- plantation under FK506. Correlation between OGTT and insulin requirement.

Kazunari Tanabe, Kota Takahashi, Shoji Koga, Tadahiko Tokumoto, Kazunori Sonda, Tetsuya Babazono, Takashi Yagisawa, Hiroshi Toma and Kazuo Ota, Tokyo, Japan (Presented by Dr. Tanabe).

The significance of recurrent or persistent gross hematuria in the bladder drained pancreatic al- Iograft patient.

Geoffrey N. Sklar, Stephen Bartlett and Stephen C. Jacobs, Baltimore, MD (Presented by Dr. Sklar).

USTVS RESIDENT AWARD - RESEARCH (INTRODUCTION BY DAVID A. HATCH, PRESIDENT, USTVS) Graft hyporeactivity after donor specific bone marrow.

Mark Rigney, Marc Gignac, Barbara Rominski, Albin Gritsch, Rosemary Hoffman and Mark L. Jordan, Pittsburgh, PA (Presented by Dr. Rigney).

Nitric oxide production in renal ischemia- reperfusion injury in the rat: implications for renal transplantation.

Daniel A. Shoskes, Yining Xie and Avraam Grinvald, Torrance, CA (Presented by Dr. Shoskes).

Urinary nitric oxide synthase activity is elevated with renal transplant rejection.

Shannon D. Smith, Marcia A. Wheeler, Erik D. Weiss, William C. Sessa, Naomi Saito, Mark I. Lorber, Hubert S. Swana and Robert M. Weiss, New Haven, CT (Presented by Dr. Smith).

Effects of tacrollmus and cyclosporine on renal microcirculation and nitric oxide production.

Yoshihiko Watarai, Mitsuhiro Yoshioka, Hiroko Togashi, Toshimori Seki, Hideya Saito and Tomohiko Koyanagi, Sapporo, Japan (Presented by Dr. Watarai).

165